BUSINESS
Alembic Pharmaceuticals gets USFDA’s final approval for Cyclophosphamide Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for…
Alembic Pharmaceuticals
BUSINESS
Alembic Pharmaceuticals zooms on getting final nod for Ketorolac Tromethamine Injection
Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on…
BUSINESS
Alembic Pharma rises as its arm gets USFDA’s nod for Diclofenac Sodium Topical Gel
Alembic Pharmaceuticals is currently trading at Rs. 701.80, up by 0.65 points or 0.09% from its previous closing of Rs. 701.15 on…
BUSINESS
Alembic Pharmaceuticals rises on getting USFDA tentative nod for Dasatinib tablets
Alembic Pharmaceuticals is currently trading at Rs. 735.70, up by 3.60 points or 0.49% from its previous closing of Rs. 732.10 on…
BUSINESS
Alembic Pharmaceuticals trades higher on getting final nod from USFDA for Pirfenidone Tablets
Alembic Pharmaceuticals is currently trading at Rs. 767.75, up by 7.35 points or 0.97% from its previous closing of Rs. 760.40 on…
BUSINESS
Alembic Pharmaceuticals gains on getting USFDA’s final approval for Entacapone tablets
Alembic Pharmaceuticals is currently trading at Rs. 823.50, up by 7.30 points or 0.89% from its previous closing of Rs. 816.20 on…
BUSINESS
Alembic Pharmaceuticals rises on getting USFDA’s final nod for Doxycycline Hyclate Delayed release tablets
Alembic Pharmaceuticals is currently trading at Rs. 812.00, up by 2.40 points or 0.30% from its previous closing of Rs. 809.60 on…